BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 25865813)

  • 1. The Cost-Utility of Total Hip Arthroplasty: Earlier Intervention, Improved Economics.
    Lavernia CJ; Iacobelli DA; Brooks L; Villa JM
    J Arthroplasty; 2015 Jun; 30(6):945-9. PubMed ID: 25865813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative outcomes and cost-utility following surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee: part 2--estimated lifetime incremental cost-utility ratios.
    Rampersaud YR; Tso P; Walker KR; Lewis SJ; Davey JR; Mahomed NN; Coyte PC
    Spine J; 2014 Feb; 14(2):244-54. PubMed ID: 24239803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining Cost-Effectiveness of Total Hip and Knee Arthroplasty Using the Short Form-6D Utility Measure.
    Elmallah RK; Chughtai M; Khlopas A; Bhowmik-Stoker M; Bozic KJ; Kurtz SM; Mont MA
    J Arthroplasty; 2017 Feb; 32(2):351-354. PubMed ID: 27665243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.
    Chang RW; Pellisier JM; Hazen GB
    JAMA; 1996 Mar; 275(11):858-65. PubMed ID: 8596224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.
    Haentjens P; De Groote K; Annemans L
    Arch Orthop Trauma Surg; 2004 Oct; 124(8):507-17. PubMed ID: 15365714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsuspected Malignancies in Routine Femoral Head Histopathologic Examination During Primary Total Hip Arthroplasty: Cost-Effectiveness Analysis.
    Liow MHL; Agrawal K; Anderson DW; Freiberg AA; Rubash HE; Kwon YM
    J Arthroplasty; 2017 Mar; 32(3):735-742. PubMed ID: 27697361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Cost-Effectiveness of Dual Mobility Implants for Primary Total Hip Arthroplasty: A Computer-Based Cost-Utility Model.
    Barlow BT; McLawhorn AS; Westrich GH
    J Bone Joint Surg Am; 2017 May; 99(9):768-777. PubMed ID: 28463921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-utility of metal-on-metal hip resurfacing compared to conventional total hip replacement in young active patients with osteoarthritis.
    Heintzbergen S; Kulin NA; Ijzerman MJ; Steuten LM; Werle J; Khong H; Marshall DA
    Value Health; 2013; 16(6):942-52. PubMed ID: 24041344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of preoperative patient characteristics on the cost-effectiveness of total hip replacement: a cohort study.
    Vogl M; Wilkesmann R; Lausmann C; Plötz W
    BMC Health Serv Res; 2014 Aug; 14():342. PubMed ID: 25128014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of antibiotic-impregnated bone cement used in primary total hip arthroplasty.
    Cummins JS; Tomek IM; Kantor SR; Furnes O; Engesaeter LB; Finlayson SR
    J Bone Joint Surg Am; 2009 Mar; 91(3):634-41. PubMed ID: 19255224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
    Schousboe JT; Brown GA
    J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does age or bilateral disease influence the value of hip arthroplasty?
    Lawless BM; Greene M; Slover J; Kwon YM; Malchau H
    Clin Orthop Relat Res; 2012 Apr; 470(4):1073-8. PubMed ID: 22131126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis of primary total hip replacement.
    O'Shea K; Bale E; Murray P
    Ir Med J; 2002 Jun; 95(6):177-80. PubMed ID: 12171266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and cost-effectiveness 1 year after total hip arthroplasty.
    Lavernia CJ; Alcerro JC
    J Arthroplasty; 2011 Aug; 26(5):705-9. PubMed ID: 20870386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of periacetabular osteotomy.
    Sharifi E; Sharifi H; Morshed S; Bozic K; Diab M
    J Bone Joint Surg Am; 2008 Jul; 90(7):1447-56. PubMed ID: 18594092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the cost-effectiveness of total hip and knee replacement: a health economic analysis.
    Jenkins PJ; Clement ND; Hamilton DF; Gaston P; Patton JT; Howie CR
    Bone Joint J; 2013 Jan; 95-B(1):115-21. PubMed ID: 23307684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative outcomes and cost-utility after surgical treatment of focal lumbar spinal stenosis compared with osteoarthritis of the hip or knee--part 1: long-term change in health-related quality of life.
    Rampersaud YR; Lewis SJ; Davey JR; Gandhi R; Mahomed NN
    Spine J; 2014 Feb; 14(2):234-43. PubMed ID: 24325880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs.
    Räsänen P; Paavolainen P; Sintonen H; Koivisto AM; Blom M; Ryynänen OP; Roine RP
    Acta Orthop; 2007 Feb; 78(1):108-15. PubMed ID: 17453401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term complications have more effect on cost-effectiveness of THA than implant longevity.
    Shearer DW; Youm J; Bozic KJ
    Clin Orthop Relat Res; 2015 May; 473(5):1702-8. PubMed ID: 25560958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.